The inauguration ceremony, held at the Translational Health Science and Technology Institute, witnessed the unveiling of the Genetically Defined Human Associated Microbial Culture Collection Facility.
In a significant stride towards advancing health research capabilities in Asia, Union Minister Dr. Jitendra Singh inaugurated the continent’s first “Pre-clinical Network Facility” today. The facility, established under the Coalition of Epidemic Preparedness Innovations (CEPI) at the Regional Centre of Biotechnology in Faridabad, marks a pivotal development in bolstering India’s research infrastructure.
The inauguration ceremony, held at the Translational Health Science and Technology Institute (THSTI), witnessed the unveiling of the Genetically Defined Human Associated Microbial Culture Collection (Ge-HuMic) Facility. This state-of-the-art repository aims to provide essential microbial cultures to various research institutions, universities, and industries engaged in research and development.
Dr. Jitendra Singh, who oversees the Ministry of Science and Technology, emphasized the strategic importance of these initiatives in fostering collaborations both domestically and internationally. The facility, equipped with cutting-edge capabilities including handling BSL3 pathogens, positions India as a key player in global health research efforts.
Underlining the broader impact of such advancements, Dr. Singh highlighted the signing of over a dozen agreements and Memoranda of Understanding (MoUs) with the private sector. These collaborations, facilitated by the Department of Biotechnology, are geared towards accelerating vaccine development for critical diseases such as Nipah virus, influenza, and other respiratory ailments.
COVID-19 pandemic
Speaking at the fourteenth foundation day of THSTI, Dr. Jitendra Singh commended the institute’s rapid growth since its inception, attributing its success to visionary leadership and pivotal research contributions. Reflecting on the institute’s critical role during the COVID-19 pandemic, he underscored its efforts in developing emergency-approved vaccines and treatments, reaffirming India’s stature in preventive healthcare.
Dr. Rajesh Gokhale, Secretary of the Department of Biotechnology, reiterated the department’s commitment to supporting innovative research initiatives despite resource constraints. He highlighted the institute’s breakthroughs in developing monoclonal antibodies for diseases like Nipah virus, underscoring their impact on global health outcomes.
The event also featured notable healthcare professionals including Dr. K. Srinath Reddy, former President of the Public Health Foundation of India, and Dr. Kathikeyan, Director of THSTI. Their presence underscored the collaborative efforts between academia, industry, and government in driving forward groundbreaking research.
The inauguration marks a milestone in India’s scientific journey, showcasing its capacity to lead advancements in health research and innovation. As the nation continues to navigate contemporary health challenges, such initiatives are poised to strengthen India’s position as a frontrunner in global healthcare innovation.
